PUBLIC CONTRACT · 2024

Aquisição de Anagrelida 0.5 mg cáps, Apalutamida 60 mg comp, Golimumab 50 mg/0.5 ml sol inj caneta 0.5 ml SC, Guselcumab 100 mg/1 ml sol inj caneta 1 ml SC, Imunoglobulina antilinfócitos (coelho) 25 mg/5 ml pó conc sol inj fr IV, Micofenolato de mofetil 1000 mg/5 ml pó susp oral fr 175 ml, Ofatumumab 20 mg/0.4 ml sol inj caneta 0.4 ml SC, Sunitinib 12.5 mg cáps e Tacrolímus 0.5 mg cáps LP

Contract value
€1,280.00
Signed on
10 December 2024
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11075141

PUBLISHED DESCRIPTION

Anagrelida 0.5 mg cáps, Apalutamida 60 mg comp, Golimumab 50 mg/0.5 ml sol inj caneta 0.5 ml SC, Guselcumab 100 mg/1 ml sol inj caneta 1 ml SC, Imunoglobulina antilinfócitos (coelho) 25 m

Parties involved

Place of performance
Portugal, Lisboa, Lisboa
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Bidder
roche farmaceutica quimica · Tax ID 500233810
Bidder
Accord Healthcare, Unipessoal · Tax ID 508622263
Bidder
SANOFI- PRODUTOS FARMACÊUTICOS,LDA. · Tax ID 500134960
Bidder
JANSSEN-CILAG FARMACÊUTICA, LDA · Tax ID 500189412
Bidder
MYLAN, LDA · Tax ID 502248793
Bidder
GENERIS – FARMACEUTICA, S.A. · Tax ID 508107997
Bidder
Astellas · Tax ID 502540249

Values and timeline

Contract price
€1,280.00
Procedure base price
€1,615,754.39
Total effective price
Not reported on Portal BASE
Publication date
10 December 2024
Award date
4 December 2024
Signing date
10 December 2024
Performance period
21 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7307969

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts